Clinical trial
Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)
NCT00135811 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00135811 |
|---|---|
| Title | Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT) |
| Official title | Focal Segmental Glomerulosclerosis Clinical Trial |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | The Cleveland Clinic |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glomerulosclerosis, Focal |
| Intervention type | Drug |
| Interventions | Cyclosporin, MMF and Dexamethasone |
| Enrollment | 207 |
| Start date | Nov 1, 2004 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Aug 26, 2005 |
| Last update posted | May 22, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: